The table below shows Nurix Therapeutics, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
-
-
$76.99M
$38.63M
$29.75M
$17.82M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$316.90M
$221.63M
$189.15M
$184.50M
$116.43M
$66.49M
SG&A
$52.74M
NRIX annual revenue (10-K history)
Nurix Therapeutics, Inc. reported annual revenue of $83.98M for fiscal year 2025. That is up 54.0% from $54.55M in fiscal 2024. Over the 7 fiscal years shown, annual revenue grew from $31.11M (FY 2019) to $83.98M. Figures come from the company's audited annual reports as filed with the SEC.